Cases of VITT have a high probability of positivity for anti-PF4 antibody, with a positive rate of 91%, but the causal relationship between thrombosis after mRNA vaccination and PF4 antibody is unclear and warrants further research [8, 17]. This evidence concerns the gene PF4 and Venous thrombosis.